These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Phosphine chalcogenides and their derivatives from red phosphorus and functionalized pyridines, imidazoles, pyrazoles and their antimicrobial and cytostatic activity. Malysheva S; Kuimov V; Belovezhets L; Belogorlova N; Borovskaya M; Borovskii G Bioorg Chem; 2023 Mar; 132():106363. PubMed ID: 36702003 [TBL] [Abstract][Full Text] [Related]
31. Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones. Mazimba O; Wale K; Loeto D; Kwape T Bioorg Med Chem; 2014 Dec; 22(23):6564-6569. PubMed ID: 25456077 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, potentiometric and antimicrobial studies on metal complexes of isoxazole Schiff bases. Prashanthi Y; Kiranmai K; Subhashini NJ; Shivaraj Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):30-5. PubMed ID: 17913572 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents. Rao YJ; Sowjanya T; Thirupathi G; Murthy NYS; Kotapalli SS Mol Divers; 2018 Nov; 22(4):803-814. PubMed ID: 29869169 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, analgesic, anti-inflammatory and in vitro antimicrobial activities of some novel isoxazole coupled quinazolin-4(3H)-one derivatives. Saravanan G; Alagarsamy V; Dineshkumar P Arch Pharm Res; 2021 Aug; 44(8):1-11. PubMed ID: 24155019 [TBL] [Abstract][Full Text] [Related]
35. Isoxazole ring as a useful scaffold in a search for new therapeutic agents. Sysak A; Obmińska-Mrukowicz B Eur J Med Chem; 2017 Sep; 137():292-309. PubMed ID: 28605676 [TBL] [Abstract][Full Text] [Related]
36. Pyrrolo-isoxazole: a key molecule with diverse biological actions. Anand P; Singh B Mini Rev Med Chem; 2014; 14(7):623-7. PubMed ID: 23373657 [TBL] [Abstract][Full Text] [Related]
37. SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria. Dokla EME; Abutaleb NS; Milik SN; Kandil EAEA; Qassem OM; Elgammal Y; Nasr M; McPhillie MJ; Abouzid KAM; Seleem MN; Imming P; Adel M Eur J Med Chem; 2023 Feb; 247():115040. PubMed ID: 36584632 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological screening of some pyridinylpyrazole and pyridinylisoxazole derivatives as potential anti-inflammatory, analgesic, antipyretic and antimicrobial agents. El-Hawash SA; Soliman R; Youssef AM; Ragab HM; Elzahhar PA; El-Ashmawey IM; Abdel Wahab AE; Shaat IA Med Chem; 2014 May; 10(3):318-38. PubMed ID: 24032466 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. Pae AN; Kim HY; Joo HJ; Kim BH; Cho YS; Choi KI; Choi JH; Koh HY Bioorg Med Chem Lett; 1999 Sep; 9(18):2679-84. PubMed ID: 10509915 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids. Jazayeri S; Moshafi MH; Firoozpour L; Emami S; Rajabalian S; Haddad M; Pahlavanzadeh F; Esnaashari M; Shafiee A; Foroumadi A Eur J Med Chem; 2009 Mar; 44(3):1205-9. PubMed ID: 18950903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]